Oncology Kits By Illumina

Flexible

Low to high throughput, handles all single cell assays.

Accessible

Enjoy economies of scale with larger-scope experiments

Easy to use

Simple upgrades, intuitive interface, direct support

TruSight Oncology 500 Portofolio

In the pursuit of personalized oncology, the TruSight Oncology 500 Portfolio from Illumina stands as a beacon of innovation, delivering a comprehensive suite of genomic solutions

TruSight Hereditary Cancer Panel

In the realm of precision oncology, the TruSight Hereditary Cancer Panel from Illumina stands at the forefront, offering a powerful genomic solution to empower individuals and families

AmpliSeq BRCA 1 & 2

IBRCA1/2 germline mutation analysis (NGS) is employed to assist in determining the necessity of targeted therapy and whether more radical surgical interventions are required